Dasatinib is a kinase inhibitor used to treat chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). It works by inhibiting the BCR-ABL fusion protein, which drives the proliferation of cancerous cells. Dasatinib is effective in managing specific types of blood cancers. In summary, Dasatinib is crucial for treating certain leukemias.
Dasatinib inhibits the activity of BCR-ABL tyrosine kinase, blocking the signaling pathways that promote cancer cell proliferation.
No published brands for this salt yet.